BerandaUTH • FRA
add
United Therapeutics Corp
Tutup sebelumnya
€272,50
Rentang tahun
€240,70 - €381,20
Kapitalisasi pasar
13,89Â M USD
Volume Rata-Rata
5,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 794,40Â jt | 17,22% |
Biaya operasional | 318,10Â jt | 26,08% |
Laba bersih | 322,20Â jt | 5,09% |
Margin laba bersih | 40,56 | -10,34% |
Penghasilan per saham | 6,63 | 7,46% |
EBITDA | 403,60Â jt | 9,82% |
Tarif pajak efektif | 23,92% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,32Â M | 22,66% |
Total aset | 7,74Â M | 19,22% |
Total liabilitas | 936,70Â jt | -19,05% |
Total ekuitas | 6,81 M | — |
Saham yang beredar | 45,11 jt | — |
Harga terhadap nilai buku | 1,80 | — |
Tingkat pengembalian aset | 12,70% | — |
Tingkat pengembalian modal | 13,92% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 322,20Â jt | 5,09% |
Kas dari operasi | 461,20Â jt | 22,50% |
Kas dari investasi | -164,70Â jt | -122,40% |
Kas dari pembiayaan | -93,80Â jt | 91,22% |
Perubahan kas bersih | 202,70Â jt | 362,79% |
Arus kas bebas | 290,66Â jt | 1,42% |
Tentang
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Didirikan
1996
Kantor pusat
Situs
Karyawan
1.305
